Pathology peak signs MOU

Pathology peak signs MOU

InGeNA has formed an alliance with Pathology Technology Australia to collaborate on advocacy and education around precision health. Pathology Technology Australia is the peak body representing Australian sponsors, manufacturers and distributors of in vitro diagnostics...
InGeNA to be an industry voice for Australian Genomics

InGeNA to be an industry voice for Australian Genomics

InGeNA will provide a united industry voice when it acts as the Industry Advisory Group to the Australian Genomics Health Alliance (Australian Genomics). InGeNA and Australian Genomics have agreed to collaborate and work together on sharing information and developing...
Webinar introduces InGeNA alliance

Webinar introduces InGeNA alliance

This free public webinar will introduce InGeNA strategy, engagement and industry collaborations and offer a taste of what you’ll see at the HealthData21 conference. InGeNA will bring together industry experts from across Australia for the first time at this national...
First digital genomics blueprint

First digital genomics blueprint

The Queensland Government working collaboratively with other health jurisdictions and research groups, has delivered the first digital genomics blueprint, which will serve as a national framework to support the management of genomic information and the rapid and safe...
InGeNA contributing to public consultation

InGeNA contributing to public consultation

InGeNA is contributing to the Genomics Health Futures Mission (GHFM) public consultation on the Roadmap, Implementation Plan and Summary of Recommendations from the Scientific Strategy Committee Report. GHFM is a Mission of the Medical Research Future Fund (MRFF) with...
Message from the Chair of InGeNA David Bunker

Message from the Chair of InGeNA David Bunker

Realising the full potential of genomics to personalise healthcare is a compelling vision, but now the real work begins in how to implement it. InGeNA was established to help bring the vision of precision health to fruition, where Australian citizens are the...
First national event for InGeNA

First national event for InGeNA

The InGeNA national conference will take place on 27 May 2021 alongside the annual health data conference of the Australasian Institute of Digital Health. HealthData21 is the first time the genomics industry has joined forces for a public event. Look out for program...
Bringing the consumer voice to the fore

Bringing the consumer voice to the fore

Welcome to the patient organisation representatives assisting InGeNA programs to ensure we have the most current consumer voice in everything we do. Jan Mumford, Executive Director of Genetic Alliance Australia, and Heather Renton, CEO and Founder of Syndromes Without...
Future thinking: Quantifying the benefits of genomics

Future thinking: Quantifying the benefits of genomics

InGeNA has engaged Deloitte Access Economics to produce a report on quantifying the benefits of genomics to Australia and look at future opportunities for the genomics industry. Once complete later this year, the report will provide a focal point for raising awareness...